Researchers will develop a novel cell culture model that will be used to test vaccination and therapeutic approaches to protect cats from common respiratory viruses, such as feline herpesvirus.

Researchers will investigate a simple, safe and cost-effective anesthetic technique for reducing abdominal pain in cats that undergo spay surgery.

Researchers will develop advanced DNA-based techniques for characterizing feline soft-tissue sarcomas, which may help veterinarians provide a more comprehensive diagnosis and improve their ability to choose the most appropriate clinical management strategies for these cancers.

Researchers will investigate a new treatment for feline oral cancers, using small molecular inhibitors.

Researchers will identify mutations in the virus that causes feline infectious peritonitis (FIP), allowing for improved diagnosis and treatment of this fatal infectious disease in cats.

Researchers will investigate the effectiveness of a clot buster in cats with severe heart disease.

Researchers will investigate the effectiveness of a transdermal gel formulation of a drug used to treat cats with congestive heart failure.

The research fellow will study feline red blood cells to learn more about why these cells are more susceptible to oxidative injury in cats compared to other animals, especially in diabetic cats.

Researchers will determine the effectiveness of and optimal way to administer the pain-relieving drug fentanyl in alpacas.

Researchers will determine safe and effective dosing for two commonly used nonsteroidal anti-inflammatory drugs – Flunixin Meglumine and Firocoxib – in African and Asian elephants.